Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Comparing Oral Preparation With Macrogol (Moviprep) and Natriumdihydrogenphosphatdihydrat (Phosphoral)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01705262
Recruitment Status : Terminated (Phophoral was no longer used as a preparation before coloscopies at OUH)
First Posted : October 12, 2012
Last Update Posted : April 5, 2017
Sponsor:
Information provided by (Responsible Party):
Anne Reiss Axelsen, Odense University Hospital

Brief Summary:
The purpose of this study is to determine whether Moviprep or Phosphoral is the best method of bowel preparation before colonoscopy - seen by the patients and by the endoscopist.

Condition or disease
Colonoscopy

Layout table for study information
Study Type : Observational
Actual Enrollment : 80 participants
Observational Model: Case-Only
Time Perspective: Prospective
Study Start Date : October 2010
Actual Primary Completion Date : October 2012
Actual Study Completion Date : October 2012

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Colonoscopy

Group/Cohort
u-65 M
Male patients under 65
u-65 K
Female patients under 65 years old
o-65 -K
Female patients over 65 years
O-65 M
Male patients over 65 years




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 85 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Patients referred to colonoscopy by the house doctors
Criteria

Inclusion Criteria:

  • primary diagnostic colonoscopy,
  • colonoscopy as a follow-up,
  • intended therapeutic colonoscopy.

Exclusion Criteria:

  • patients younger than 18 years
  • pregnancy
  • known bowl obstructions
  • known inflammatory colon disease
  • known kidney disease
  • phenylketonuri
  • glucose-6-phospat deficiency

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01705262


Locations
Layout table for location information
Denmark
Surgery department
Odense, Denmark, 5250
Sponsors and Collaborators
Odense University Hospital

Layout table for additonal information
Responsible Party: Anne Reiss Axelsen, MD, Odense University Hospital
ClinicalTrials.gov Identifier: NCT01705262     History of Changes
Other Study ID Numbers: AAX-001
First Posted: October 12, 2012    Key Record Dates
Last Update Posted: April 5, 2017
Last Verified: April 2017
Keywords provided by Anne Reiss Axelsen, Odense University Hospital:
compliance
Bowel preparations
Moviprep
Phosphoral